STAT March 18, 2025
Hal Rosenbluth

But reforming them could

As a reformed hypochondriac, I’m extremely vulnerable to the allure of pharmaceutical ads. I self-referred for GLP-1s years ago after seeing advertisements, and even though I am a diabetic, what followed were horrific health...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Pharma Dodges The Tariff Bullet — But For How Long?
PBM Private Labeling Boosts Biosimilars, Raises Concerns
Biotech ‘megarounds’ hold steady as startups, VCs wait on IPOs
How BioPharma Can Improve Consumers’ Experience and Health
The Go-To Law Firms For Healthcare and Life Sciences

Share This Article